CRL Stock Analysis: Buy, Sell, or Hold?
CRL - Charles River Laboratories International, Inc.
$286.83
-8.18 (-2.77%)
âŧ
5d:
-2.58%
30d:
+1.59%
90d:
+24.34%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When CRL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CRL is fairly priced but lacks strong directional signals. At 9.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CRL is fairly priced but lacks strong directional signals. At 9.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$322.80
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$200.44
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRL is currently trading at $286.83, which is considered fair relative to its 30-day fair value range of $277.73 to $294.70. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.5) compared to its historical average (17.2). At these levels, the market is pricing in 9.3% annual earnings growth.
Technical Outlook: Technically, CRL is in a strong uptrend. Immediate support is located at $275.88, while resistance sits at $298.98.
Market Sentiment: CRL scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRL is in a strong uptrend. Immediate support is located at $275.88, while resistance sits at $298.98.
Market Sentiment: CRL scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$277.73 -
$294.70
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($305.00)
- BULLISH: Expecting earnings turnaround to 9.3% growth with -2.7% revenue growth
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$277.73 -
$294.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$275.88
Resistance Level
$298.98
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.52
Wall Street Target
$305.00
(+6.3%)
Revenue Growth (YoY)
-2.7%
Earnings Growth (YoY)
-17.3%
Profit Margin
-6.0%
Valuation Premium vs History
+9.3% premium
PE vs Historical
22.5 vs 17.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.3%
(market-implied from PE analysis)
1-Year Target
$313.51
(+9%)
2-Year Target
$342.66
(+20%)
3-Year Target
$374.53
(+31%)
3-Yr Target (if PE normalizes)
(PE: 23â17)
PE COMPRESSION
$286.06
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.5, Growth: 12.2%)
$405.49
(+41%)
Base:
(SPY PE: 20.4, Growth: 12.2%)
$367.32
(+28%)
Bear:
(PE: 17.2, Growth: 12.2%)
$309.70
(+8%)
Share & Embed Analysis
Last updated: October 02, 2026 3:45 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
Data refreshes hourly during market hours. Next update: 4:45 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
LH
Laboratory Corporation oâĻ |
STRONG BUY
20 analysts |
$345 | 65 BUY |
